383 results on '"Lacombe, Denis"'
Search Results
2. Analysis of the characteristics and the degree of pragmatism exhibited by pragmatic-labelled trials of antineoplastic treatments
3. Inclusion of functional measures and frailty in the development and evaluation of medicines for older adults
4. Defining the role of real-world data in cancer clinical research: The position of the European Organisation for Research and Treatment of Cancer
5. Current models, challenges and best practices for work conducted between European academic cooperative groups and industry
6. Diverging EU health regulations: The urgent need for co ordination and convergence
7. Prospective data registration and clinical trials for particle therapy in Europe
8. A unique research infrastructure from the European Organisation for Research and Treatment of Cancer (EORTC) to optimize long-term follow up of patients-the YOU (Your Outcome Update) protocol: Rationale, scope, design and research opportunities
9. ‘Mind the gap’ between the development of therapeutic innovations and the clinical practice in oncology: A proposal of the European Organisation for Research and Treatment of Cancer (EORTC) to optimise cancer clinical research
10. Multidisciplinary quality assurance and control in oncological trials: Perspectives from European Organisation for Research and Treatment of Cancer (EORTC)
11. Societal challenges of precision medicine: Bringing order to chaos
12. Identifying critical steps towards improved access to innovation in cancer care: a European CanCer Organisation position paper
13. Sharing human samples and patient data: Opening Pandora’s box
14. Safeguarding the future of independent, academic clinical cancer research in Europe for the benefit of patients
15. Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study
16. EORTC is 60 - and far from contemplating retirement
17. The European Cancer Patient’s Bill of Rights, update and implementation 2016
18. QUARTET: A SIOP Europe project for quality and excellence in radiotherapy and imaging for children and adolescents with cancer
19. How do cancer clinicians perceive real-world data and the evidence derived therefrom? Findings from an international survey of the European Organisation for Research and Treatment of Cancer
20. Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors
21. Advancing academia-driven treatment optimisation in oncology: Launch of the EMA Cancer Medicines Forum
22. Drug Development in Europe : The Academic Perspective
23. EORTC Research and Development: Achievements and Future Perspectives
24. Imaging biomarker roadmap for cancer studies
25. Collaboration between EORTC and JCOG—how to accelerate global clinical research partnership
26. New prognostic factors and calculators for outcome prediction in patients with recurrent glioblastoma: A pooled analysis of EORTC Brain Tumour Group phase I and II clinical trials
27. Major achievements of the EORTC Cutaneous Lymphoma Task Force (CLTF)
28. EORTC topics in neurooncology: The long path from a focus on neurological complications of cancer towards molecularly defined trials and therapies in neurooncology
29. 50 years of the EORTC and the central role of the EORTC Headquarters
30. Code of practice needed for samples donated by trial participants
31. Towards a Cancer Mission in Horizon Europe
32. Accelerating regulatory approval of anticancer therapies: Benefits, drawbacks and recommendations for a more sustainable approach
33. The Porto European Cancer Research Summit 2021
34. Design, organisation and impact of treatment optimisation studies in breast, lung and colorectal cancer: The experience of the European Organisation for Research and Treatment of Cancer
35. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
36. MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status
37. Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3
38. The dream and reality of histology agnostic cancer clinical trials
39. OPINION: European perspective for effective cancer drug development
40. Clinical research in Europe: Who do we do all that for?
41. Towards personalized medicine in the EU: what is needed to facilitate the complex international clinical research?
42. Current models, challenges and best practices for work conducted between European academic cooperative groups and industry
43. The Conduct of Clinical Trials for Medicinal Products in Europe in the Light of the European Clinical Trials Directive. Review of Regulatory and Practical Aspects in the Different Countries
44. Conduite des essais cliniques de médicaments au niveau européen depuis la directive européenne essais cliniques. Revue des aspects réglementaires et pratiques dans différents pays
45. Cross-Border Access to Clinical Trials in the EU: Exploratory Study on Needs and Reality
46. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
47. Phase II study of XR5000 (DACA), an inhibitor of topoisomerase I and II, administered as a 120-h infusion in patients with advanced ovarian cancer*
48. Past, Current, and Future Cancer Clinical Research Collaborations: The Case of the European Organisation for Research and Treatment of Cancer
49. Towards a cancer mission in Horizon Europe: recommendations
50. The European Organisation for Research and Treatment of Cancer, State of Science in radiation oncology and priorities for clinical trials meeting report
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.